El síndrome de Guillain-Barré y su relación con la infección por los virus del ZIKV y covid-19: un análisis comparativo de casos
| datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
| dc.contributor.advisor | Navarro Quiroz, Antonio | |
| dc.contributor.advisor | Navarro Quiroz, Roberto Carlos | |
| dc.contributor.advisor | Vargas Manotas, José Enrique | |
| dc.contributor.author | Barreto Molina, Ana Carolina | |
| dc.contributor.author | Rizcala García, Karen Helena | |
| dc.contributor.author | Vélez Ascanio, Joaquín Fernando | |
| dc.date.accessioned | 2021-12-01T15:47:52Z | |
| dc.date.available | 2021-12-01T15:47:52Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Introducción: El Síndrome de Guillain-Barré (SGB) es un polineuroradiculopatía aguda inmunomediada que causa con más frecuencia debilidad adquirida y en la mayoría de los casos está precedida de un cuadro infeccioso, pudiendo causar como complicación disfunción respiratoria o disfunción autonómica. Actualmente debido a la pandemia por Covid-19 que surgió en enero del 2020 se encuentra en investigación la correlación del virus SARS COV-2 debido al alto número de casos descritos con SGB concomitante o posterior a una infección por este virus, creando la teoría incluso de que la presentación de este síndrome puede ser una complicación de esta patología. Objetivo: Desarrollar un análisis comparativo entre la participación de las infecciones por Virus Zika y SARS-CoV-2 en el desarrollo del SGB. | spa |
| dc.description.abstract | Introduction: Guillain-Barré Syndrome (GBS) is an acute immune-mediated polyneuroradiculopathy that more frequently causes acquired weakness and in most cases is preceded by an infectious condition, which can cause respiratory dysfunction or autonomic dysfunction as a complication. Currently due to the Covid-19 pandemic that emerged in January 2020, the correlation of the SARS COV-2 virus is under investigation due to the high number of cases described with concomitant GBS or subsequent to an infection by this virus, creating the theory even that the presentation of this syndrome may be a complication of this pathology. Objective: To develop a comparative analysis between the participation of Zika and SARS-CoV-2 infections in the development of Guillain-Barré Syndrome (GBS). | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/9158 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Zika | spa |
| dc.subject | ZIKV | spa |
| dc.subject | COVID 19 | spa |
| dc.subject | SARS-CoV2 | spa |
| dc.subject | Síndrome de Guillain Barré | spa |
| dc.subject | poliradiculoneuropatía | spa |
| dc.subject | Guillain Barre Syndrome | eng |
| dc.subject | polyradiculoneuropathy | eng |
| dc.title | El síndrome de Guillain-Barré y su relación con la infección por los virus del ZIKV y covid-19: un análisis comparativo de casos | spa |
| dc.type.driver | info:eu-repo/semantics/other | spa |
| dc.type.spa | Otros | spa |
| dcterms.references | Walling AD, Dickson G. Guillain-Barré syndrome. Am Fam Physician. 2013 Feb;87(3):191–7. | eng |
| dcterms.references | Laura Isabel Betancur Ocampo; Astrid Milena Bedoya ; Jaiberth Antonio Cardona-Arias. Relación entre síndrome de Guillain-Barré e infección por el virus Zika. Arch Med. 2016;12(3). | spa |
| dcterms.references | Zuberbühler P, Conti ME, León Cejas L, Maximiliano González F, Bonardo P, Miquelini A, et al. Síndrome de Guillain-Barré asociado a infección por COVID-19: revisión de casos publicados. Rev Neurol. 2021;72(06):203 | spa |
| dcterms.references | McGrogan A, Madle GC, Seaman HE, De Vries CS. The epidemiology of Guillain-Barré syndrome worldwide: A systematic literature review. Neuroepidemiology. 2009;32(2):150–63. | eng |
| dcterms.references | Alter M. The epidemiology of Guillain-Barré syndrome. Ann Neurol. 1990;27 Suppl:S7-12. | eng |
| dcterms.references | Brasil P, Pereira JP, Raja Gabaglia C, Damasceno L, Wakimoto M NR et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro: Preliminary Report. N Engl J Med. 2016;6(2). | eng |
| dcterms.references | World Health Organization. http://apps.who.int/iris/bitstream/handle/10665/204348/zikasitrep_5Feb2016_eng.pdf;jsessionid=7451A0AEE3A77C86C1BA757F5BA1E6FB?sequence=1. ZIKA SITUATION REPORT. | eng |
| dcterms.references | Susy Chang-Quezada EH. Síndrome de Guillain-Barré en pacientes con antecedentes de virus epidémicos de Zika y SARS-CoV-2. Una revisión narrativa. Ciencia, Tecnol y Salud. 7((3)):396–409. | spa |
| dcterms.references | Dash S, Pai AR, Kamath U, Rao P. Pathophysiology and diagnosis of Guillain-Barré syndrome-challenges and needs. Int J Neurosci. 2015;125(4):235–40. | eng |
| dcterms.references | PAHO. https://www.paho.org/es/temas/zika. Zika. p. 1. | eng |
| dcterms.references | Esteban Molina A, Mata Martínez M, Sánchez Chueca P, Carrillo López A S, Val I. Sanjuan-Villarreal TA. Síndrome de Guillain-Barré asociado a infección por COVID- 19. Med Intensiva. 2020;44((8))::513–4. | spa |
| dcterms.references | Roberts CM ,Levi M MM y co. COVID-19: un trastorno multisistémico complejo . Br J Anaesth. 2020;125:238–42. | spa |
| dcterms.references | Chen Z JWE. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20(0):529–36. | eng |
| dcterms.references | Weaver SC, Costa F, Garcia-Blanco MA, Ko AI, Ribeiro GS, Saade G et al. Zika virus: History, emergence, biology, and prospects for control. Antivir Res. 130:69–80. | eng |
| dcterms.references | DICK GW CSHI. Aislamientos y especificidad serológica. Trans R Soc Trop Med Hyg. 1952;46(5):509–20. | spa |
| dcterms.references | FN. M. Virus del Zika: un informe sobre tres casos de infección humana durante una epidemia de ictericia en Nigeria. Trans R Soc Trop Med Hyg. 1954;48(2):139–45. | spa |
| dcterms.references | Baba SS FAO. Estudios preliminares sobre el uso de técnicas inmunoabsorbentes en fase sólida para la detección rápida de IgM del virus de Wesselsbron (WSLV) por inhibición de la hemaglutinación. Infect Dis Comp Immunol Microbiol. 22(1):71–9. | eng |
| dcterms.references | Hogendorf A, Stanczyk-Przyluska A, Sieniwicz-Luzenczyk K, Wiszniewska M, Arendarczyk J, Banasik M et al. Is there any association between secretory IgA and lactoferrin concentration in mature human milk and food allergy in breastfed children. Med Wieku Rozw. 2013;17(1):47–52 | eng |
| dcterms.references | OMS. The-history-of-zikavirus/www.who.int/news-room/feature-stories/detail/. 2016; | eng |
| dcterms.references | Campos GS BAS. Brote de virus Zika, Bahía, Brasil. Emerg Infect Dis. 21((10):):1885-6. | eng |
| dcterms.references | Zanluca C, Melo VC, Mosimann AL, Santos GI SCL. Primer informe de transmisión autóctona del virus del Zika en Brasil. Mem Inst Oswaldo Cruz. 2015;110(4):569-72. | spa |
| dcterms.references | Hennessey M, Fischer M SJ. Zika Virus Spreads to New Areas - Region of the Americas, May 2015-January 2016. MMWR Morb Mortal Wkly Rep. 65((3))::55-8. | eng |
| dcterms.references | Citil Dogan A, Wayne S, Bauer S, Ogunyemi D, Kulkharni SK, Maulik D et al. The Zika virus and pregnancy: evidence, management, and prevention. J Matern Neonatal Med. ;30((4))::386–96. | eng |
| dcterms.references | Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V, Huy R, Guzman H, Tesh RB WSG characterization of Z virus strains: geographic expansion of the A lineage. P. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. LoS Negl Trop Dis. 2012;6((2):):e1477 | eng |
| dcterms.references | Miner JJ DM. Zika Virus Pathogenesis and Tissue Tropism. Cell Host Microbe. ;21((2):):134–42. | eng |
| dcterms.references | Plourde AR BEA. Literature Review of Zika Virus. Emerg Infect Dis. 22((7):):1185–92. | eng |
| dcterms.references | Aliota MT, Caine EA, Walker EC, Larkin KE, Camacho E OJ. Characterization of Lethal Zika Virus Infection in AG129 Mice. PLoS Negl Trop Dis. 10((4):):e0004682. | eng |
| dcterms.references | Hills SL, Fischer M PL. Epidemiology of Zika Virus Infection. J Infect Dis 017 Dec 16;216(suppl_10)S868–74. 216((suppl_10))::S868–74. | eng |
| dcterms.references | GW. D. Virus Zika. II. Patogenicidad y propiedades físicas. Trans R Soc Trop Med Hyg. 1952;46:521–34. | spa |
| dcterms.references | Diagne CT, Diallo D, Faye O, Ba Y, Faye O GA et al. Potencial de Aedes spp. De Senegal seleccionadas. mosquitos (Diptera: Culicidae) para transmitir el virus del Zika. BMC Infect Dis. 2015;15:492. | spa |
| dcterms.references | Wolfe ND, Kilbourn AM, Karesh WB, Rahman HA, Bosi EJ, Cropp BC, Andau M, Spielman A GD. Sylvatic transmission of arboviruses among Bornean orangutans. Am J Trop Med Hyg. 64(5-6)::310. | eng |
| dcterms.references | Zé-Zé L, Prata MB, Teixeira T, Marques N, Mondragão A, Fernandes R, Saraiva da Cunha J AM. Zika virus infections imported from Brazil to Portugal, 2015. IDCases 2. ;4:46-9. | pt |
| dcterms.references | Zammarchi L, Stella G, Mantella A, Bartolozzi D, Tappe D, Günther S, Oestereich L, Cadar D, Muñoz-Fontela C, Bartoloni A S-CJ. Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications. J Clin Virol. (63)::32-5. | eng |
| dcterms.references | Brasil P, Calvet GA SA et al. Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical Characterization, Epidemiological and Virological Aspects. PLoS Negl Trop Dis. 2016;10:e0004636. | eng |
| dcterms.references | Musso D NEC-L. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 20((10)):O595-6. | eng |
| dcterms.references | Agumadu VC RK. Zika Virus: A Review of Literature. Cureus. ;10((7))::e3025–e3025. | eng |
| dcterms.references | Chen LH HD. Zika Virus: Rapid Spread in the Western Hemisphere. Ann Intern Med. (164):613–5. | eng |
| dcterms.references | Morel Ayala Z, Greco J. Enfermedad de Kawasaki. Revisión de la literatura. Pediatría (Asunción). 2014;41(3):223–34. | spa |
| dcterms.references | Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith ARY, Goo L, et al. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Rep. 2016;16(6):1485–91. | eng |
| dcterms.references | Dai L, Song J, Lu X, Deng Y-Q, Musyoki AM, 43. Dai L, Song J, Lu X, Deng Y-Q, Musyoki AM, Cheng H et al. Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody. Cell Host Microbe. 2016;19((5):):696–704. | eng |
| dcterms.references | Sapparapu G, Fernandez E, Kose N, Cao B, Fox JM, Bombardi RG et al. N human. Antibodies prevent Zika virus replication and fetal disease in mice. Nature. 2016;540((7633))::443–7. | eng |
| dcterms.references | Atif M, Azeem M, Sarwar MR BA. Zika virus disease: a current review of the literature. Infection. 2016;44((6):):695–705. | eng |
| dcterms.references | https://es.statista.com/estadisticas/1104227/numero-acumulado-de-casos-de-coronavirus-covid-19-en-el-mundo-enero-marzo/. | spa |
| dcterms.references | https://www.paho.org/es/noticias/11-3-2020-oms-caracteriza-covid-19-como-pandemia. | spa |
| dcterms.references | Burrell C., Howard C. M. ; P E. Fenner and White’s Medical Virology 5th Edición. 2016. 1p p. | eng |
| dcterms.references | Hu, B., Guo, H., Zhou P et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev. Microbiol 19,. :141–154. | eng |
| dcterms.references | Kramer A. SIK. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130. | eng |
| dcterms.references | Francisco Javier Díaz-Castrillón AIT-M. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. 2020;24(3). | spa |
| dcterms.references | Roland Mojica. Pandemic COVID-19, the new health emergency of international concern: a review.”. Med Fam Semer. 2020;46(Supplement 1):65–77. | eng |
| dcterms.references | Irlanda Alvarado Amador,* Jessica Bandera Anzaldo LECB, Romero GFP, García¶ AA. Etiología y fisiopatología del SARS-CoV-2. Rev Lat Infect Pediatr. 2020;33((s1):):s5–9. | spa |
| dcterms.references | Kampf G., Todt D. PSSP. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020; | eng |
| dcterms.references | Bai Y, Yao L, Wei T et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 323((14)):1406–1407 | eng |
| dcterms.references | Huang C., Wang Y., Li X., Ren L. ZJH. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:((10223)):497–506. | eng |
| dcterms.references | Salud OM de la. Vigilancia mundial de la infección humana por el nuevo coronavirus (2019-nCoV). 2020. | spa |
| dcterms.references | Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Heal. ;13((5))::667–73. | eng |
| dcterms.references | Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). ;395((10223))::507–13. | eng |
| dcterms.references | Peiris JSM GYY. Síndrome respiratorio agudo severo. Nat Med. 2004;10((12))::S88-S97. | eng |
| dcterms.references | Ali M. Zaki, M.D., Ph.D., Sander van Boheemen, M.Sc., Theo M. Bestebroer, B.Sc., Albert D.M.E. Osterhaus, D.V.M., Ph.D., and Ron A.M. Fouchier PD. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N Engl J Med. 367:1814–20. | eng |
| dcterms.references | Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, Butt KM, Wong KL, Chan KW, Lim W, Shortridge KF, Yuen KY, Peiris JS PL. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Sci . ;302((5643))::276-8. | eng |
| dcterms.references | Brennan G, Kitzman JO, Rothenburg S, Shendure J GA. Adaptive gene amplification as an intermediate step in the expansion of virus host range. Pathog, PLoS . 13;(10(3))::e1004002. | eng |
| dcterms.references | Dabanch J. BASIC INFORMATION ABOUT EPIDEMIOLOGY, ORIGIN SOURCE, STRUCTURE AND PATHOGENICITY OF SARS-COV-2 FOR CLINICIANS. Rev Médica Clínica Las Condes. 2021;32:14–9. | eng |
| dcterms.references | Cruz-Durán Alejandro* F-GNE. Fisiopatología de la COVID-19. LUX MEDICA. 2021;31–28. | spa |
| dcterms.references | Chaolin Huang 1, Yeming Wang 2, Xingwang Li 3, Lili Ren 4, Jianping Zhao 5, Yi Hu 6, Li Zhang 1, Guohui Fan 7, Jiuyang Xu 8, Xiaoying Gu 7, Zhenshun Cheng 9, Ting Yu 1, Jiaan Xia 1, Yuan Wei 1, Wenjuan Wu 1, Xuelei Xie 1, Wen Yin 6, Hui Li 2, Min Liu 10, BC 15. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. ;395((10223))::497-506. | eng |
| dcterms.references | Qun Li, M.Med., Xuhua Guan, Ph.D., Peng Wu, Ph.D., Xiaoye Wang, M.P.H., Lei Zhou, M.Med., Yeqing Tong, Ph.D., Ruiqi Ren, M.Med., Kathy S.M. Leung, Ph.D., Eric H.Y. Lau, Ph.D., Jessica Y. Wong, Ph.D., Xuesen Xing, Ph.D., Nijuan Xiang, M.Med. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020;382:1199–207. | eng |
| dcterms.references | Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, et al. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020/05/12. 2020 Jun;41(6):1351–4. | eng |
| dcterms.references | Di Nardo M, van Leeuwen G, Loreti A, Barbieri MA, Guner Y, Locatelli F et al. A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children. Pediatr Res 2. 2021;(5):(1101–8). | eng |
| dcterms.references | Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M PL. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. 66((4))::549-555. | eng |
| dcterms.references | Wölfel, R., Corman, V.M., Guggemos W et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469. | eng |
| dcterms.references | He, X., Lau, E.H.Y., Wu P et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26:672–675. | eng |
| dcterms.references | Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC HP. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. ;53((3))::404-412. | eng |
| dcterms.references | Lasso FA, Zamora Bastidas TO, Andrés J, García P, Idrobo BD, Médica C. Cryptococcal cerebellitis in no-VIH patient Cerebelitis criptococócica en paciente VIH negativo. Colomb Med. 2017;48(48):94–7. | eng |
| dcterms.references | Tian Y, Rong L, Nian W HY. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther . ;51((9))::843-851. | eng |
| dcterms.references | Forni G, Mantovani A, Forni G, Mantovani A, Moretta L, Rappuoli R et al. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021;28((2):):626–39. | eng |
| dcterms.references | S. J. Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature. 579((7798))::321–2. | eng |
| dcterms.references | Sansone P, Giaccari LG, Aurilio C, Coppolino F, Esposito V, Fiore M, et al. Post-infectious guillain–barré syndrome related to sars-cov-2 infection: A systematic review. Life. 2021;11(2):1–16. | eng |
| dcterms.references | Abolmaali M, Heidari M, Zeinali M, Moghaddam P. Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series. J Clin Neurosci 2021. 2021;83:119–22. | eng |
| dcterms.references | Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol [Internet]. 2019;15(11):671–83. Available from: http://dx.doi.org/10.1038/s41582-019-0250-9 | eng |
| dcterms.references | KC. WE. Guillain-Barré Syndrome. Mayo Clin Proc. 2007;92((3)):467–79. | eng |
| dcterms.references | Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717–27. | eng |
| dcterms.references | Laparidou D, Curtis F, Akanuwe J, Jackson J, Hodgson TL, Siriwardena AN. Patients’ experiences and perceptions of Guillain-Barré syndrome: A systematic review and meta-synthesis of qualitative research. PLoS One [Internet]. 2021;16(2 February):1–20. Available from: http://dx.doi.org/10.1371/journal.pone.0245826 | eng |
| dcterms.references | Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol [Internet]. 2016;12(11):1175–89. Available from: http://dx.doi.org/10.1080/1744666X.2016.1193006 | eng |
| dcterms.references | Jacobs BC, Rothbarth PH, Van Der Meche FG, Herbrink P, Schmitz PI DKME. The spectrum of antecedent infections in Guillain-Barre syndrome: a casecontrol study. Neurology. 1998;51((4)):1110-5. | eng |
| dcterms.references | Musso D, Cao-Lormeau VM, Gubler DJ. Zika virus: Following the path of dengue and chikungunya? Lancet [Internet]. 2015;386(9990):243–4. Available from: http://dx.doi.org/10.1016/S0140-6736(15)61273-9 | eng |
| dcterms.references | Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith ARY, Goo L, Platt DJ, Mascola JR, Graham BS, Mulligan MJ, Diamond MS LJP. Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Rep. 2016;16((6)):1485-1491 | eng |
| dcterms.references | Ansar V, Valadi N. Guillain-Barré Syndrome. Prim Care - Clin Off Pract [Internet]. 2015;42(2):189–93. Available from: http://dx.doi.org/10.1016/j.pop.2015.01.001 | eng |
| dcterms.references | Madariaga MLL, Shanmugarajah K, Michel SG, Villani V, LaMuraglia GM, Torabi R et al. Immunomodulatory strategies directed toward tolerance of vascularized composite allografts. Transplantation. ;99((8))::1590–7. | eng |
| dcterms.references | Wijdicks EFM, Klein CJ. Guillain-Barré Syndrome. Mayo Clin Proc. 2017;92(3):467–79. | eng |
| dcterms.references | Phillips Morales Ó. Actualización en el Síndrome de Guillain-Barré. Rev Medica Sinerg. 2019;4(11):e290. | spa |
| dcterms.references | Van Den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Doorn PA. Guillain-Barré syndrome: Pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–82. | eng |
| dcterms.references | Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008 Apr;336(7650):924–6. | eng |
| dcterms.references | Rajdev K, Victor N, Buckholtz ES, Hariharan P, Saeed MA, Hershberger DM, et al. A Case of Guillain-Barré Syndrome Associated With COVID-19. J Investig Med high impact case reports. 2020;8:2324709620961198. | eng |
| dcterms.references | Khalifa M, Zakaria F, Ragab Y, Saad A, Bamaga A, Emad Y, et al. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child. J Pediatric Infect Dis Soc. 2020 Sep;9(4):510–3. | eng |
| dcterms.references | Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Vol. 41, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. Italy; 2020. p. 1657–8. | eng |
| dcterms.references | Tiet MY, AlShaikh N. Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK. BMJ Case Rep. 2020 Jul;13(7):e236536. | eng |
| dcterms.references | Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain–Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020 Apr;382(26):2574–6. | eng |
| dcterms.references | Juliao Caamaño DS, Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020;77:230–2. | eng |
| dcterms.references | Frank CHM, Almeida TVR, Marques EA, de Sousa Monteiro Q, Feitoza PVS, Borba MGS, et al. Guillain–Barré Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient. J Trop Pediatr. 2021 Jun;67(3). | eng |
| dcterms.references | Manganotti P, Bellavita G, D’Acunto L, Tommasini V, Fabris M, Sartori A, et al. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: A case series. J Med Virol. 2020/07/27. 2021 Feb;93(2):766–74. | eng |
| dcterms.references | R. HELBOK ET AL. Guillain-Barre syndrome in a patient with antibodies againstSARS-COV-2. Eur J Neurol. 2020;1754–6. | eng |
| dcterms.references | Elie Naddaf M, Ruple S. Laughlin M, Christopher J. Klein M. Guillain-Barré Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection. Mayo Clin Proc. 2020;95(8):1797–809. | eng |
| dcterms.references | Marta-Enguita J, Rubio-Baines I, Gastón-Zubimendi I. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2 TT - Síndrome de Guillain-Barré fatal tras infección por el virus SARS-CoV-2. Neurologia. 2020/04/18. 2020 May;35(4):265–7. | eng |
| dcterms.references | Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature. J Peripher Nerv Syst. 2020 Jun 1;25(2):204–7. | eng |
| dcterms.references | Su XW, Palka S V, Rao RR, Chen FS, Brackney CR, Cambi F. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia. Muscle Nerve. 2020/06/01. 2020 Aug;62(2):E48–9. | eng |
| dcterms.references | doardo Agosti corresponding authoEr AG, D’Amore F, Vinacci G, Sergio Balbi 1 and Davide Locatelli1. Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review. Neurol Sci. 42(2):: 607–612. | eng |
| dcterms.references | Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Vol. 19, The Lancet. Neurology. 2020. p. 383–4. | eng |
| dcterms.references | Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci. 2020/04/15. 2020 Jun;76:233–5 | eng |
| dcterms.references | Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, et al. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol neuroinflammation. 2020 Apr;7(4):e741. | eng |
| dcterms.references | Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Abu-Rumeileh S, Piscaglia MG, et al. Guillain-Barré syndrome following COVID-19: new infection, old complication? J Neurol. 2020/04/24. 2020 Jul;267(7):1877–9. | eng |
| dcterms.references | El Otmani H, El Moutawakil B, Rafai M-A, El Benna N, El Kettani C, Soussi M, et al. Covid-19 and Guillain-Barré syndrome: More than a coincidence! Rev Neurol (Paris). 2020/04/24. 2020 Jun;176(6):518–9. | eng |
| dcterms.references | Coen M, Jeanson G, Culebras Almeida LA, Hübers A, Stierlin F, Najjar I, et al. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun. 2020/04/28. 2020 Jul;87:111–2. | eng |
| dcterms.references | Camdessanche J-P, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris). 2020/04/15. 2020 Jun;176(6):516–8. | eng |
| dcterms.references | Ahmed Virani, Rabold E, Hanson At, Aaron Haag, Rawiya Elrufay, c Tariq Cheema, a Marvin Balaan a and NB. Guillain-Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020;20:e00771. | eng |
| dcterms.references | Riva N, Russo T, Falzone YM, Strollo M, Amadio S, Del Carro U, et al. Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report. J Neurol. 2020/05/26. 2020 Sep;267(9):2492–4. | eng |
| dcterms.references | Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, et al. Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol neuroinflammation. 2020 May;7(5):e785. | eng |
| dcterms.references | do Rosário MS, de Jesus PAP, Vasilakis N, Farias DS, Novaes MAC, Rodrigues SG, et al. Guillain-Barré Syndrome After Zika Virus Infection in Brazil. Am J Trop Med Hyg. 2016/09/19. 2016 Nov;95(5):1157–60. | eng |
| dcterms.references | Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastère S, Valour F, Baudouin L, Mallet H P, Musso D GF. Zika virus infection complicated by Guillain-Barré syndrome – case report, French. Euro Surveill. 2013;19(9):pii=20720 | eng |
| dcterms.references | Fabrizius RG, Anderson K, Hendel-Paterson B, Kaiser RM, Maalim S, Walker PF. Guillain-Barré Syndrome Associated with Zika Virus Infection in a Traveler Returning from Guyana. Am J Trop Med Hyg. 2016/10/17. 2016 Nov;95(5):1161–5. | eng |
| dcterms.references | Wright JK, Castellani L, Lecce C, Khatib A, Bonta M, Boggild AK. Zika Virus-Associated Aseptic Meningitis and Guillain–Barre Syndrome in a Traveler Returning from Latin America: a Case Report and Mini-Review. Curr Infect Dis Rep. 2019;21(1):3. | eng |
| dcterms.references | Langerak T, Yang H, Baptista M, Doornekamp L, Kerkman T, Codrington J, et al. Zika Virus Infection and Guillain–Barré Syndrome in Three Patients from Suriname. Front Neurol. 2016;7:233. | eng |
| dcterms.references | Zambrano H, Waggoner JJ, Almeida C, Rivera L, Benjamin JQ, Pinsky BA. Zika Virus and Chikungunya Virus CoInfections: A Series of Three Cases from a Single Center in Ecuador. Am J Trop Med Hyg. 2016/07/11. 2016 Oct;95(4):894–6. | eng |
| dcterms.references | Akrami KM, de Nogueira BMF, do Rosário MS, de Moraes L, Cordeiro MT, Haddad R, et al. The re-emergence of Zika in Brazil in 2020: a case of Guillain Barré Syndrome during the low season for arboviral infections. J Travel Med. 2020 Nov;27(7). | eng |
| dcterms.references | Rozé Benoît, Najioullah Fatiha, Fergé Jean-Louis, Apetse Kossivi, Brouste Yannick, Cesaire Raymond, Fagour Cédric, Fagour Laurence, Hochedez Patrick, Jeannin Séverine, Joux Julien, Mehdaoui Hossein, Valentino Ruddy, Signate Aïssatou, Cabié André on behalf of the GZWG. Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016. Euro Surveill. 2016;21(9):pii=30154. | eng |
| dcterms.references | Sanchez Silva GL, Carrillo DA, Moncayo Alvarado H. Fiebre Zika y síndrome de Guillain-Barré. Presentación de 2 casos. Acta Colomb Cuid Intensivo. 2016;16(3):238–41. | spa |
| dcterms.references | Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet. 2021 Mar;397(10280):1214–28. | eng |
| dcterms.references | María Guimaraes Rocha, Brucki SD, Lima AA de SC, Poti ÚW. Características epidemiológicas del síndrome de Guillain-Barré en São Paulo, Brasil. Arq Neuro-Psiquiatr. 4AD;62(1). | spa |
| dcterms.references | Esposito, S., & Longo MR. Guillain-Barré syndrome. Autoimmun Rev. 2017;16(1):96-101. | eng |
| dcterms.references | Hills SL, Fischer M, Petersen LR. Epidemiology of Zika Virus Infection. J Infect Dis. 2017 Dec;216(suppl_10):S868–74. | eng |
| dcterms.references | Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya J GM. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Review of Clinical. Immunology. 2016;12(11):1175–89. | eng |
| dcterms.references | Nanda SK, Jayalakshmi S, Ruikar D, Surath M. Twelfth cranial nerve involvement in Guillian Barre syndrome. J Neurosci Rural Pract. 2013 Jul;4(3):338–40. | eng |
| dcterms.references | Singhal V, Bhat KG. Guillain-Barre syndrome with hyperreflexia: A variant. J Pediatr Neurosci. 2011 Jul;6(2):144–5. | eng |
| dcterms.references | Mulroy E, Anderson NE. Altered mental status in “Guillain-Barré syndrome” –a noteworthy clinical clue. Ann Clin Transl Neurol. 2020 Dec;7(12):2489–507. | eng |
| dcterms.references | Rath J, Zulehner G, Schober B, Grisold A, Krenn M, Cetin H, et al. Cerebrospinalfluid analysis in Guillain–Barré syndrome: value of albumin quotients. J Neurol. 2021;268(9):3294–300. | eng |
| dcterms.references | Mishu B, Ilyas AA, Koski CL et al . Evidencia serológica de infección previa por Campylobacter jejuni en pacientes con síndrome de Guillain-Barré. Ann Intern Med. 1993;(118):947–53. | spa |
| dcterms.references | Parra B, Lizarazo J, Jiménez-Arango JA, Zea-Vera AF, González-Manrique G, Vargas J, et al. Guillain–Barré Syndrome Associated with Zika Virus Infection in Colombia. N Engl J Med. 2016 Oct 20;375(16):1513–23. | eng |
| dcterms.references | ||
| oaire.version | info:eu-repo/semantics/acceptedVersion | spa |
| sb.programa | Especialización en Neurología | spa |
| sb.sede | Sede Barranquilla | spa |